OptraHealth Sues Invitae for Infringement of AI-Based Chatbot Patent
OptraHealth claims that Invitae has violated its patent since the latter added results return capabilities to its Gia chatbot in February 2021.
The lead investigators have also spun out a company, Isabl, aiming to make the approach available to the broader community.
Thermo Fisher Scientific, Qatar Genome Program Partner to Develop Microarray for Arab Populations
Under the agreement, the organizations will develop a custom Axiom genotyping array based on whole-genome sequencing data from 19 Arab countries.
Medical Genome Initiative Develops Best Practices, Standards for Clinical Whole-Genome Sequencing
Premium
The nine-institute organization, founded by Illumina, recently issued guidelines for the interpretation and reporting of clinical whole-genome sequencing tests.